A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
Both the 80-mg dose and the 100-mg dose of resmetirom were superior to placebo with respect to NASH resolution and improvement in liver fibrosis by at least one stage. (Funded b...